Launching a
category-defining therapy.
A pharmaceutical launch sits at the intersection of medicine, marketing, and regulation. Every word, every visual, every graphic has to clear medical, legal, and brand review — each with non-overlapping requirements. The work is translation as much as it is design.
We partnered on the digital go-to-market for a therapy considered a category-defining breakthrough, addressing one of the most pressing health concerns of the moment.
Dense clinical data — mechanism of action, efficacy, dosage logic, patient fit — became medical illustration designed for a clinician with limited time and high stakes. The campaign's spine was a streamlined digital platform serving as resource hub and launchpad, built so the next launch could reuse the architecture.
Templates and visual systems were designed to clear those reviews without friction — the approval logic built into the format, so it didn't have to be re-argued asset by asset.
The work enabled clinicians to evaluate and prescribe with confidence. We became a long-term creative partner for the client and the agency teams around them. Specific data points, outcomes, and branding sit behind a non-disclosure boundary.